Thermo Fisher Scientific (TMO) Increases Availability of COVID-19 Testing with Sample Collection Kit from Everlywell
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Thermo Fisher Scientific (TMO) Tops Q3 EPS by $1.32, Revenues Beat
October 21, 2020 6:02 AM EDTThermo Fisher Scientific (NYSE: TMO) reported Q3 EPS of $5.63, $1.32 better than the analyst estimate of $4.31. Revenue for the quarter came in at $8.52 billion versus the consensus estimate of $7.65 billion.
Third Quarter 2020 Highlights
Third quarter revenue increased 36% to $8.52 billion.Third quarter GAAP diluted earnings per share (EPS) increased 157% to $4.84.Third quarter adjusted EPS increased 91% to $5.63.Generated $2.0 billion of COVID-19 related revenue in the quarter and returned the base business to growth.Further expanded our global pandemic response, including launching the Amplitude Solution to automate high-throughput PCR-based testing, adding... More